Clinical Trials Browser

Chronic Disease, Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT02626312 2026-04-16

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

Phase 1 Active not recruiting

36 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT03520660 2026-04-14

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Phase 4 Active not recruiting

121 enrolled

Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT07529262 2026-04-14

AspiRe HCC

Phase 3 Not yet recruiting

890 enrolled

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

NCT02968810 2026-04-13

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

Phase 2 Active not recruiting

52 enrolled 15 charts

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT05874492 2026-04-13

FIBROTHERME

Phase NA Recruiting

110 enrolled

BreastHead & Neck

Breast Neoplasms, Fibrosis, Head and Neck Neoplasms

NCT06096779 2026-04-03

Kirros

Phase 2 Recruiting

30 enrolled

Gastrointestinal

Digestive System Neoplasms, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT05586516 2026-03-30

A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer

Phase 1/2 Completed

16 enrolled

Gastrointestinal

Fibrosis, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Clinical Trials

PREMIUM

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

AspiRe HCC

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

FIBROTHERME

Kirros

A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer